Point72 Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
2025
Q1
Hold
2019
Q4
Sell
2019
Q3
$265K Sell
2019
Q2
$332K Buy
2019
Q1
$162K Buy